Meet Kazia's Scientific Advisor, Dr Karen Ferrante
Автор: Kazia Therapeutics
Загружено: 2018-04-18
Просмотров: 287
Описание:
This is a short, edited video of a longer interview that Kazia looks forward to sharing in the near future.
Dr Karen Ferrante is a haematologist-oncologist with over twenty years of experience in clinical oncology drug development, spanning both large pharmaceutical companies and fast-growing biotechs.
Dr Ferrante is a member of the Scientific Advisory Board of Kazia Therapeutics Limited (ASX: KZA, NASDAQ: KZIA).
In this excerpt of an interview led by NDF Research Senior Analyst Stuart Roberts, Dr Ferrante shares her experience with drug regulatory bodies and her in-depth understanding about the drug approval process. She examines the context in which Kazia’s drug for glioblastoma, GDC-0084, is being developed, considering particularly that it has been granted Orphan Drug Designation by the US FDA.
Learn more about Kazia Therapeutics’ Scientific Advisory Board via this link:
https://www.kaziatherapeutics.com/abo...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
